Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2

被引：85

作者：

Yu, Fei ^{[1
]}

Xiang, Rong ^{[1
]}

Deng, Xiaoqian ^{[1
]}

Wang, Lili ^{[2
]}

Yu, Zhengsen ^{[1
]}

Tian, Shijun ^{[1
]}

Liang, Ruiying ^{[1
]}

Li, Yanbai ^{[1
]}

Ying, Tianlei ^{[3
]}

Jiang, Shibo ^{[3
]}

机构：

[1] Hebei Agr Univ, Coll Life Sci, Baoding, Peoples R China

[2] Hebei Agr Univ, Res Ctr Chinese Jujube, Baoding, Peoples R China

[3] Fudan Univ, Sch Basic Med Sci, CAMS, Key Lab Med Mol Virol,MOE,NHC, Shanghai, Peoples R China

来源：

SIGNAL TRANSDUCTION AND TARGETED THERAPY | 2020年 / 5卷 / 01期

基金：

中国国家自然科学基金;

关键词：

ACUTE RESPIRATORY SYNDROME; CORONAVIRUS SPIKE PROTEIN; POTENT NEUTRALIZATION; VIRUS; IMMUNOPROPHYLAXIS; IDENTIFICATION; GENERATION; EPITOPES; FRAGMENT; VACCINE;

D O I：

10.1038/s41392-020-00318-0

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The outbreaks of severe acute respiratory syndrome (SARS) and Coronavirus Disease 2019 (COVID-19) caused by SARS-CoV and SARS-CoV-2, respectively, have posed severe threats to global public health and the economy. Treatment and prevention of these viral diseases call for the research and development of human neutralizing monoclonal antibodies (NMAbs). Scientists have screened neutralizing antibodies using the virus receptor-binding domain (RBD) as an antigen, indicating that RBD contains multiple conformational neutralizing epitopes, which are the main structural domains for inducing neutralizing antibodies and T-cell immune responses. This review summarizes the structure and function of RBD and RBD-specific NMAbs against SARS-CoV and SARS-CoV-2 currently under development.

引用

页数：12

共 50 条

[21] Attenuated Influenza Virions Expressing the SARS-CoV-2 Receptor-Binding Domain Induce Neutralizing Antibodies in Mice
Loes, Andrea N.
Gentles, Lauren E.
Greaney, Allison J.
Crawford, Katharine H. D.
Bloom, Jesse D.
VIRUSES-BASEL, 2020, 12 (09):
[22] Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto
Young-Jun Park
Martina Beltramello
Alexandra C. Walls
M. Alejandra Tortorici
Siro Bianchi
Stefano Jaconi
Katja Culap
Fabrizia Zatta
Anna De Marco
Alessia Peter
Barbara Guarino
Roberto Spreafico
Elisabetta Cameroni
James Brett Case
Rita E. Chen
Colin Havenar-Daughton
Gyorgy Snell
Amalio Telenti
Herbert W. Virgin
Antonio Lanzavecchia
Michael S. Diamond
Katja Fink
David Veesler
Davide Corti
Nature, 2020, 583 : 290 - 295
[23] Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
Kim, Byoung-Jun
Jeong, Hyein
Seo, Hyejun
Lee, Mi-Hyun
Shin, Hyun Mu
Kim, Bum-Joon
FRONTIERS IN IMMUNOLOGY, 2021, 12
[24] Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
Shinnakasu, Ryo
Sakakibara, Shuhei
Yamamoto, Hiromi
Wang, Po-Hung
Moriyama, Saya
Sax, Nicolas
Ono, Chikako
Yamanaka, Atsushi
Adachi, Yu
Onodera, Taishi
Sato, Takashi
Shinkai, Masaharu
Suzuki, Ryosuke
Matsuura, Yoshiharu
Hashii, Noritaka
Takahashi, Yoshimasa
Inoue, Takeshi
Yamashita, Kazuo
Kurosaki, Tomohiro
JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (12):
[25] Neutralizing and enhancing antibodies against SARS-CoV-2
Liu, Yafei
Arase, Hisashi
INFLAMMATION AND REGENERATION, 2022, 42 (01)
[26] The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2
Xiong, Hualong
Sun, Hui
Wang, Siling
Yuan, Lunzhi
Liu, Liqin
Zhu, Yuhe
Zhang, Jinlei
Huang, Yang
Qi, Ruoyao
Jiang, Yao
Ma, Jian
Zhou, Ming
Ma, Yue
Fu, Rao
Yan, Siping
Yue, Mingxi
Wu, Yangtao
Wei, Min
Wang, Yizhen
Li, Tingting
Wang, Yingbin
Zheng, Zizheng
Yu, Hai
Cheng, Tong
Li, Shaowei
Yuan, Quan
Zhang, Jun
Guan, Yi
Zheng, Qingbing
Zhang, Tianying
Xia, Ningshao
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (34)
[27] Neutralizing and enhancing antibodies against SARS-CoV-2
Yafei Liu
Hisashi Arase
Inflammation and Regeneration, 42
[28] Comparative molecular dynamics study of the receptor-binding domains in SARS-CoV-2 and SARS-CoV and the effects of mutations on the binding affinity
Rezaei, Shokouh
Sefidbakht, Yahya
Uskokovic, Vuk
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (10): : 4662 - 4681
[29] Neutralizing and Enhancing Epitopes of the SARS-CoV-2 Receptor-Binding Domain (RBD) Identified by Nanobodies
Kaewchim, Kanasap
Glab-ampai, Kittirat
Mahasongkram, Kodchakorn
Saenlom, Thanatsaran
Thepsawat, Watayagorn
Chulanetra, Monrat
Choowongkomon, Kiattawee
Sookrung, Nitat
Chaicumpa, Wanpen
VIRUSES-BASEL, 2023, 15 (06):
[30] Enhancing neutralizing antibodies against receptor binding domain of SARS-CoV-2 by a safe natural adjuvant system
Darvish, Maliheh
Moosavi-Nejad, Zahra
Siadat, Seyed Omid Ranaei
Fatemi, Fataneh
Khatibi, Ali
VIRUS RESEARCH, 2023, 326

← 1 2 3 4 5 →